VJ
Valliant John Chairman & CEO
C-suite M
US US · SEC (Form 4)
€388,309
▼ Sales (17 ops.)
Explore the complete record of transactions filed by Valliant John, Chairman & CEO. Director active across 1 companies, notably Fusion Pharmaceuticals Inc.. Cumulatively, 17 reports have been published. Total volume traded: €388k. The latest transaction was filed on 25 April 2022 — Cession. Regulator: SEC (Form 4). All data is openly available.
Declarations 17 total
€11,459 2,036 shares @ €5.628 3.0% of flow
Common Stock
SEC:0001209191-22-025783:0 · 25 Apr 2022
€2,036 367 shares @ €5.5485 0.5% of flow
Common Stock
SEC:0001209191-22-025469:0 · 20 Apr 2022
€17,615 2,600 shares @ €6.7752 4.5% of flow
Common Stock
SEC:0001209191-22-024330:0 · 11 Apr 2022
€696 100 shares @ €6.9553 0.2% of flow
Common Stock
SEC:0001209191-22-023861:0 · 6 Apr 2022
€6,999 1,000 shares @ €6.9994 1.8% of flow
Common Stock
SEC:0001209191-22-023124:0 · 1 Apr 2022
€2,021 300 shares @ €6.7372 0.5% of flow
Common Stock
SEC:0001209191-22-022034:0 · 30 Mar 2022
€3,370 500 shares @ €6.7396 0.9% of flow
Common Stock
SEC:0001209191-22-021487:0 · 25 Mar 2022
€27,339 4,000 shares @ €6.8348 7.0% of flow
Common Stock
SEC:0001209191-22-020948:0 · 22 Mar 2022
€6,132 900 shares @ €6.8137 1.6% of flow
Common Stock
SEC:0001209191-22-020316:0 · 17 Mar 2022
€8,277 1,300 shares @ €6.3666 2.1% of flow
Common Stock
SEC:0001209191-22-019224:0 · 14 Mar 2022
€5,235 822 shares @ €6.368 1.3% of flow
Common Stock
SEC:0001209191-22-018455:0 · 9 Mar 2022
€55,561 8,400 shares @ €6.6144 14.3% of flow
Common Stock
SEC:0001209191-22-017150:0 · 4 Mar 2022
€5,566 847 shares @ €6.571 1.4% of flow
Common Stock
SEC:0001209191-22-015555:0 · 1 Mar 2022
€16,386 2,500 shares @ €6.5542 4.2% of flow
Common Stock
SEC:0001209191-22-013791:0 · 24 Feb 2022
€33,956 4,898 shares @ €6.9327 8.7% of flow
Common Stock
SEC:0001209191-22-012344:0 · 18 Feb 2022
€92,831 12,600 shares @ €7.3676 23.9% of flow
Common Stock
SEC:0001209191-22-010918:0 · 15 Feb 2022
€92,831 12,600 shares @ €7.3676 100.0% of flow
Common Stock
SEC:0001209191-22-010918 · 15 Feb 2022
About Valliant John Valliant John is an insider at Fusion Pharmaceuticals Inc.